ATOH1 and colon adenocarcinoma: As for the clinicopathological characteristics, we found that COAD patients at a late clinical stage, with distant metastasis (M1), or with lymphatic metastasis (N1 and N2) often presented low ATOH1 expression (Fig. 3C–E, p < 0.05).